Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis

Journal of the American Society of Nephrology

Volumn 10, Issue 1, 1999, Pages 136-145

  Scharfer, Franz ^a   Klaus, Günter ^b   Müller Wiefel, Dirk E ^c   Mehls, Otto ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM CULTURE; CHILDHOOD DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERSENSITIVITY REACTION; INFANT; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; OTOTOXICITY; PERITONEAL DIALYSIS; PERITONITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM;

EID: 0032923518     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gokal R, Oreopoulos DG: Is long-term technique survival on continuous ambulatory peritoneal dialysis possible? Perit Dial Int 16: 553-555, 1996
2. Kindt E, Motzfeldt K, Halvorsen S, Lie SO: Protein requirements in infants and children: A longitudinal study of children treated for phenylketonuria. Am J Clin Nutr 37: 778-785, 1983
3. Andreoli SP, Langefeld CD, Stadler S, Smith P, Sears A, West K: Risks of peritoneal membrane failure in children undergoing long-term peritoneal dialysis. Pediatr Nephrol 7: 543-547, 1993
4. Millikin SP, Matzke GR, Keane WF: Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int 11: 252-2660, 1991
5. Brier ME, Aronoff GR: Initial intraperitoneal therapy for CAPD peritonitis: The Network 9 Peritonitis Study. Adv Perit Dial 10: 141-143, 1994
6. Keane WF, Everett ED, Golper TA, Gokal R, Halstenson C, Kawaguchi Y, Riella M, Vas S, Verbrugh HA: Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. Perit Dial Int 13: 14-28, 1993
7. Bonati M, Traina GL, Gentile MG, Fellin G, Rosina R, Cavenaghi L, Buniva G: Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous peritoneal dialysis. Br J Clin Pharmacol 25: 761-765, 1988
8. Dykhuizen RS, Harvey G, Stephenson N, Nathwani D, Gould IM: Protein binding and serum bactericidal activities of vancomycin and teicoplanin. Antimicrob Agents Chemother 39: 1842-1847, 1995
9. Wood MJ: The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 37: 209-222, 1996
10. Neville LO, Baillod RA, Brumfitt W, Hamilton-Miller JMT: Efficacy and safety of teicoplanin in Gram-positive peritonitis in patients on peritoneal dialysis. J Antimicrob Chemother 21 [Suppl A]: 123-131, 1988
11. Bowley JA, Pickering SJ, Scantlebury AJ, Ackrill P, Jones DM: Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 21 [Suppl A]: 133-139, 1988
12. Demotes-Mainard F, Vincon G, Ragnaud JM, Morlat P, Bannwarth B, Dangoumau J: Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis. J Clin Pharmacol 33: 475-479, 1993
13. Stea S, Bachelor T, Cooper M, de Souza P, Koenig K, Bolton WK: Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 7: 2399-2402, 1996
14. Warady BA, Hebert D, Sullivan EK, Alexander SR, Tejani A: Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents: The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 11: 49-64, 1997
15. Stein A, Baker F, Moorhouse J, Walls J: Peritonitis rate: Traditional versus low calcium dialysate. Am J Kidney Dis 26: 632-633, 1995
16. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, Finkelstein F: Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 5: 1835-1838, 1995
17. Honda M, Iitaka K, Kawaguchi H, Hoshii S, Akashi S, Kohsaka T, Tuzuki K, Yamaoka K, Yoshikawa N, Karashima S, Itoh Y, Hatae K: The Japanese National Registry data on pediatric CAPD patients: A ten-year experience. A report of the Study Group of Pediatric PD Conference. Perit Dial Int 16: 269-275, 1996
18. Cameron JS: Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis. Pediatr Nephrol 9: 647-662, 1995
19. Saklayen MG: CAPD peritonitis: Incidence, pathogens, diagnosis, and management. Med Clin North Am 74: 997-1010, 1990
20. Gupta B, Bernardini J, Piraino B: Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 28: 415-419, 1996
21. Klaus G, Schaefer F, Querfeld U, Soergel M, Wolf S, Mehls O: Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis. Adv Perit Dial 8: 302-305, 1992
22. Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR: Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 8: 965-971, 1997
23. Freiman JP, Graham DJ, Reed TG, McGoodwin EB: Chemical peritonitis following the intraperitoneal administration of vancomycin. Perit Dial Int 12: 57-60, 1992
24. Gin AS, Zhanel GG: Vancomycin-resistant enterococci. Ann Pharmacother 30: 615-624, 1996
25. Witte W: Impact of antibiotic use in animal feeding on resistance of bacterial pathogens in humans. Ciba Found Symp 207: 61-71, 1997
26. Noble WC, Virani Z, Cree RG: Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 72: 195-198, 1992
27. Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Huang CC, Kawaguchi Y, Piraino B, Riella M, Schaefer F, Vas S: Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 16: 557-573, 1996
28. Golper TA: Intermittent versus continuous antibiotics for PD-related peritonitis. Perit Dial Int 17: 11-12, 1997
29. Spivey JM: The postantibiotic effect. Clin Pharmacol 11: 865-875, 1992
30. Wust J, Auckenthaler R, Breer C, Heinzer I, Kamm W: Antibiotic sensitivity of Gram-negative bacteria in intensive care units in Switzerland. Schweiz Med Wochenschr 124: 1695-1700, 1994
31. Jarlier V, Fosse T, Philippon A: Antibiotic susceptibility in aerobic Gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med 22: 1057-1065, 1996
32. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R: Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit. Clin Infect Dis 24: 211-215, 1997